Advertisement

Vergleich der Leberresektion gegenüber der sequentiellen transarteriellen Chemoembolisation bei Hepatozellulären Karzinom im Stadium pT3 oder pT4

  • F. Hasse
  • U.-M. Mehring
  • F. Castaneda
  • H. Jäger
  • K.-D. Mathias
  • D. Löhlein
Conference paper
Part of the Langenbecks Archiv für Chirurgie book series (DTGESCHIR, volume 1996)

Comparison of Liver Resection and Sequential Transarterial, Chemoembolisation in Stage pT3 or pT4 Hepatocellular Carcinoma

Summary

Between January 1990 and January 1996, 39 consecutive patients with histologically improved pT3 or pT4 HCC tumors underwent curative resection (n = 19) or sequential transarterial chemoembolization (n =20) with a median time interval of 7 weeks up to six times with an emulsion of Lipiodol, Epirubicin and Cisplatin. The 30-day mortality rate for all sessions of TA was 3.8% vs. 21.8% in the resection group (p<0.05); the cumulative survival rate for the embolization group at 6, 12, 18 and 24 months was 72.3%, 50.1%, 41.2%, 35.4% vs. 42.1%, 31.6%, 31.6% and 14.2% following resection, which cannot be considered statistically significant. Patients with T3 and T4 HCC, treated with sequential embolization or resection, seem to have a comparable survival time.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • F. Hasse
    • 1
  • U.-M. Mehring
    • 1
  • F. Castaneda
    • 1
  • H. Jäger
    • 2
  • K.-D. Mathias
    • 2
  • D. Löhlein
    • 1
  1. 1.Chirurgische KlinikAkademisches Lehrkrankenhaus, WWU MünsterDortmundDeutschland
  2. 2.Institut für Strahlendiagnostik, Städtische Kliniken DortmundAkademisches Lehrkrankenhaus, WWU MünsterDortmundDeutschland

Personalised recommendations